Home > Insider Trading > Filing (0000096943-19-000007)

Filing Details

Accession Number:: 0000096943-19-000007
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2019-01-11 17:48:09
Reporting Period:: 2018-12-07

Accepted Time:: 2019-01-11 17:48:09
Original Submission Date:: 2018-12-10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
96943	Teleflex Inc	TFX	Surgical & Medical Instruments & Apparatus (3841)	231147939

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1242740	E Thomas Powell	550 E Swedesford Road Suite 400 Wayne PA 19087	Executive Vice President & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-12-07	5,200	$78.62	15,351	No	4	M	Direct
Common Stock	Disposition	2018-12-07	1,258	$256.77	14,093	No	4	S	Direct
Common Stock	Disposition	2018-12-07	798	$257.60	13,295	No	4	S	Direct
Common Stock	Disposition	2018-12-07	1,244	$258.75	12,051	No	4	S	Direct
Common Stock	Disposition	2018-12-07	200	$260.96	11,851	No	4	S	Direct
Common Stock	Disposition	2018-12-07	1,700	$262.50	10,151	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option / (Right to Buy)	Disposition	2018-12-07	5,200	$0.00	5,200	$78.62

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,424		2023-02-26	No	4	M	Direct

Footnotes

Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 21, 2018.
Due to a broker reporting error, the Form 4 filed on December 10, 2018 incorrectly indicated that the reporting person acquired 3,500 shares of the issuer's common stock upon exercise of the stock option. This Form 4/A is being filed to correct the number of shares of the issuer's common stock acquired by the reporting person upon exercise of the stock option from 3,500 to 5,200.
This transaction was executed in multiple trades at prices ranging from $256.19 to $257.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $257.22 to $258.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $258.34 to $259.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $260.90 to $261.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Exercisable for one-third of the shares on each of 2/26/2014, 2/26/2015 and 2/26/2016.